Market Overview

Morning Market Movers

Share:

Cubist Pharmaceuticals (NASDAQ: CBST) shares climbed 35.66% to $100.88 after Merck (NYSE: MRK) announced its plans to acquire Cubist for $102 per share in cash.

BioLineRx (NASDAQ: BLRX) shares jumped 17.47% to $1.74 after the company reported positive data from ongoing Phase 2a Study for AML treatment.

Louisiana-Pacific (NYSE: LPX) shares gained 9.85% to $17.03. Louisiana-Pacific shares have dropped 3.85% over the past 52 weeks, while the S&P 500 index has gained 14.76% in the same period.

Acceleron Pharma (NASDAQ: XLRN) rose 7.56% to $40.40. Celgene (NASDAQ: CELG) and Acceleron announced new data from Luspatercept Phase 2 clinical trial in beta-thalassemia.

Agios Pharmaceuticals (NASDAQ: AGIO) shares surged 3.42% to $109.65 after the company reported Celgene decision to extend discovery phase of global strategic collaboration to April 2016. The company also announced positive data from ongoing Phase 1 trial of AG-221 at ASH Annual Meeting.

Randgold Resources (NASDAQ: GOLD) shares jumped 2.76% to $66.64 after falling 2.26% on Friday.

Celgene (NASDAQ: CELG) shares climbed 2.42% to $116.89 after the company and Acceleron Pharma (NASDAQ: XLRN) announced new data from
Luspatercept Phase 2 clinical trial in beta-thalassemia.

The Nasdaq OMX Group (NASDAQ: NDAQ) rose 1.53% to $46.38 after analysts at Keefe Bruyette & Woods upgraded the stock from Market Perform to Outperform and raised the price target from $45 to $55.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (BLRX + AGIO)

View Comments and Join the Discussion!

UPDATE: Deutsche Bank Reiterates On Lam Research On Multiple Positive Factors

#PreMarket Prep Guest List For The Week Of December 8, 2014